Ideal Life Sciences Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Ultrabose GM 1mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults.
Tablet
Ultrabose GM 1mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ultrabose GM 1mg/500mg/0.2mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Ultrabose GM 1mg/500mg/0.2mg Tablet.
Ultrabose GM 1mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Ultrabose GM 1mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Ultrabose GM 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Ultrabose GM 1mg/500mg/0.2mg Tablet is a combination of three medications: Glimepiride, Metformin and Voglibose. This medicine is used to treat type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken with proper diet and exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin decreases glucose production in the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that reduces postprandial (after meal) glucose levels. This combination is not indicated for the treatment of type 1 diabetes.
Common side effects associated with Ultrabose GM 1mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Ultrabose GM 1mg/500mg/0.2mg Tablet should not be used in patients with known allergies to any of the components or excipients of this medicine. It is also contraindicated for patients with moderate to severe kidney disease and those with inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis, including diabetic ketoacidosis.
No, combining Ultrabose GM 1mg/500mg/0.2mg Tablet with alcohol is not advisable as this can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Ultrabose GM 1mg/500mg/0.2mg Tablet can potentially cause hypoglycemia (low blood sugar levels). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feelings of anxiety or shakiness. This risk is higher if you miss meals, consume alcohol, over-exercise or use other antidiabetic medications simultaneously. Regular blood glucose monitoring is crucial.
Store this medication in its original packaging, tightly closed. Follow the instructions provided on the package label or medication container. Discard unused medicine properly and ensure it is not consumed by children, pets, or other individuals.